Galliani G, Assandri A, Barone D, Grandi M, Mistrello G, Lancini G C
Cancer Chemother Pharmacol. 1985;14(1):74-8. doi: 10.1007/BF00552730.
L-Alanosine [L-2-amino-3(N-hydroxy-N-nitrosamino)propionic acid], a tumor-inhibiting agent, induces pregnancy arrest after single or multiple SC or PO administration to rats and hamsters. Its contragestational effects are dose- and route-dependent, with no important differences in species-sensitivity or administration schedules. L-Alanosine is maximally effective shortly (3-4 days) after implantation. Both placenta and fetus appear to be target tissues. Consistent with previous in vitro findings, adenine but not aspartic acid counteracts the contragestational action of L-alanosine. The 'contragestational test', i.e., the effect on conceptus growth, appears to be an interesting approach for learning more about the antiproliferative activity of an antineoplastic agent.
L-丙氨菌素[L-2-氨基-3(N-羟基-N-亚硝基氨基)丙酸]是一种肿瘤抑制剂,对大鼠和仓鼠单次或多次皮下或口服给药后可导致妊娠终止。其抗孕作用具有剂量和给药途径依赖性,在物种敏感性或给药方案方面无重要差异。L-丙氨菌素在植入后不久(3 - 4天)效果最佳。胎盘和胎儿似乎都是靶组织。与之前的体外研究结果一致,腺嘌呤而非天冬氨酸可抵消L-丙氨菌素的抗孕作用。“抗孕试验”,即对胚胎生长的影响,似乎是一种了解抗肿瘤药物抗增殖活性的有趣方法。